← back to search

Yuling Wu

Xiamen University · CN
Area of research
Immunology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research, Antimicrobial Resistance in Staphylococcus, and Protein purification and stability.
h-index
22
citations
1,617
works
59
NIH funding
primary concept
Medicine
email

Recent publications

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
Cancer Immunology Immunotherapy 2023cited by 97position: middledoi
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
Critical Care 2022cited by 89position: middledoi
Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome
Evidence-based Complementary and Alternative Medicine 2021cited by 6position: middledoi
The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
Evidence-based Complementary and Alternative Medicine 2020cited by 19position: middledoi
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
Journal of Clinical Oncology 2018cited by 77position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael J. Overman · The University of Texas MD Anderson Cancer Center2 papers (2018–2023)John H. Strickler · Cancer Institute (WIA)2 papers (2018–2023)Anne M. Noonan · U-M Rogel Cancer Center2 papers (2018–2023)Thomas J. George · University of Florida Health2 papers (2018–2023)Johanna C. Bendell · Roche (Switzerland)2 papers (2018–2023)Wenzhen Wu · Guangzhou University of Chinese Medicine2 papers (2020–2021)Jianhui Xie · Guangzhou University of Chinese Medicine2 papers (2020–2021)Xiaobo Yang · Guangzhou University of Chinese Medicine2 papers (2020–2021)Patricia LoRusso · University of New Haven2 papers (2018–2023)Manik Amin · Dartmouth College2 papers (2018–2023)Sandip Pravin Patel · Hindu College of Pharmacy2 papers (2018–2023)Zachary A. Cooper · AstraZeneca (Singapore)2 papers (2018–2023)Stephen Clarke · Carnegie Mellon University2 papers (2018–2023)Jayesh Desai · Peter MacCallum Cancer Centre2 papers (2018–2023) · 2 papers (2018–2023)Jiamin Xu · Guangzhou University of Chinese Medicine2 papers (2020–2021)Sang-We Kim · Université Grenoble Alpes1 papers (2023–2023)Dewei She · Amgen (United States)1 papers (2018–2018) · 1 papers (2023–2023)Minal Barve · Mary Crowley Cancer Research Center1 papers (2023–2023)